Better treatment options. Better outcomes.
Better treatment options.
Better outcomes.
Better outcomes.
Founder & Chairman of Adventus Ventures Corp, medical technology incubator/early stage funding, and entrepreneur with strong background with both start-up and large established organizations (Johnson & Johnson, St. Jude Medical). Shawn has held various leadership position; CEO, senior executive, board member, and co-founded multiple medical device companies with several successful exists: EP Dynamics, Lavita Technologies, Renal Dynamics, Vessix Vascular (acquired by BSX), Ellipse Technologies ( acquired by Nuvasive), Biosense Webster ( acquired by JNJ) & Savona Therapeutics, Oncogenics Guidance Systems. Named inventor on more than 100 issued and pending patents covering broad range of medical device technologies
20+ years in medical device development. Prior experience as General Manager and project leader for Intersect Partners where he was responsible for product design and development from feasibility through First-In-Man clinical studies for five companies. Mark has held senior management roles in engineering and operations at CardioMed Device, Sano Intelligence, Medtronic MiniMed, Glumetrics, Devax, Dexcom, Spiration and Arterial Vascular Engineering (AVE)/Medtronic. He has expertise in Nitinol, cardiovascular stents, stent grafts, stent structures consisting of all metallic and polymer implant materials, combination products (drug coatings on delivery mechanisms), delivery systems, guide wires and introducers. Mark earned his Bachelor’s degree in mechanical engineering from Rochester Institute of Technology and his M.B.A. from Argosy University in Seattle, Washington.
20 years of experience as a Technologist and Entrepreneur in the Semiconductor industry. Most recently founder and CTO of SIMAERA, a start-up company focused on GaN-on-Silicon technology for optical communications and sensor devices with operations based in Shanghai, PRC. Previous roles as an Engineering Manager and Technologist at start-up companies in the Silicon Valley, as well as at KLA Tencor and Intel Corporation. Justin earned a Bachelor of Science degree in Materials Science from MIT in 1995 and a Master of Science degree in Materials Science and Engineering from Carnegie Mellon University in 1997. He is an inventor on more than 15 U.S. patents.
Founder and President of Nanostructures and over 35 years of experience in research and development in the electronics industry. He has been responsible for the microfabrication activities at Nanostructures since its beginning in 1987. His experience includes a wide range of silicon and thin film processing techniques with an emphasis on micromachining and related processes. His design experience includes pressure, acoustic, and acceleration sensors, micromachined mirrors, optical fiber and laser diode mounts, microfluidics, retinal implants, and a variety of membrane related structures. Dr. Mauger graduated with a B.A. degree in physics and mathematics from Drew University in 1975 and an M.S. and Ph.D. degrees in physics from Cornell University in 1979 and 1982. He is the author of several papers and is an inventor on 9 U.S. patents.
Dan has over 25 years of experience building healthcare technology companies. He is currently the President and CFO of Axonics Modulation Technologies, a medical device company treating overactive bladder. Previously COO & CFO of Vessix Vascular and General Manager responsible for post-acquisition integration after the acquisition by Boston Scientific.
A world renowned thought leader in the endovascular field, Dr. Razavi is an Interventional Radiologist at St. Joseph’s Vascular Institute in Orange, California, USA. He was formerly Associate Professor at the Stanford University Medical Center and the Director of the fellowship program at the Stanford Vascular Center. Co-founder & advisor of Neuravi ( acquired by JNJ in 2017) & has acted as a Scientific Advisory Board member or Consultant to Abbott Laboratories, Johnson and Johnson, Edwards Life Science, Covidien, C.R. Bard and a number of other small and large companies. Also an experienced entrepreneur, he co-founded Trivascular Inc, a company that developed aortic vascular endografts and which was sold to Boston Scientific in 2003. He has authored or co-authored more than 250 scientific publications. He received his medical degree from the University of Southern California and completed his Radiology residency at UCLA.